Reading this on a mobile device? Try our optimized mobile version here:

November 3, 2010
Sign upForwardArchiveAdvertise
News for and about dermatologic surgeons

  Healthy, Beautiful Skin 
  • Alarming number of patients think screening prevents skin cancer
    Slightly more than 72% of 487 patients surveyed at a University of Pittsburgh School of Medicine dermatology clinic believed that screening prevents skin cancer. The belief is "inaccurate and without scientific basis," said Dr. Laura Korb Ferris. Nearly 90% believed that screenings reduce the risk of death from skin cancer. All of the patients surveyed were at the clinic for skin cancer screening. Medscape (free registration) (10/27) LinkedInFacebookTwitterEmail this Story
  • Children get bullied for psoriasis, survey finds
    A National Psoriasis Foundation survey found about 44% of children with psoriasis had been bullied at least once during the previous six months and about 38% of those cases were the direct result of their skin condition. The survey also revealed that bullying caused emotional problems, including anxiety and crying, in some cases. Bloomberg Businessweek (10/29) LinkedInFacebookTwitterEmail this Story
  • Other News
Non-Invasive Technology to Grow Your Practice.
The VASER® Shape MC1™ System is an innovative, non-surgical technology with specialized handpieces for ultrasound diathermy and zonal lymphatic massage. This unique, computerized technology is a perfect complement to your existing aesthetic practice, allowing you to treat patients who want to achieve their desired result without surgical body treatments. Learn More.
  Tools of the Trade 
  • Dermatologists report a shortage of cantharidin
    The FDA is allegedly blocking imports of cantharidin, long used by pediatric dermatologists to treat molluscum contagiosum but never approved by the FDA. In a Jan. 7, 1999, Federal Register notice, the agency called cantharidin -- a substance derived from crushed Chinese blister beetles -- extremely toxic. "The raw material is very caustic and requires extreme safety precautions when handling, but once compounded with collodion, it becomes a very effective agent for use in dermatology," said Deborah Grafelman, president of Delasco Dermatologic Lab and Supply. (11/1) LinkedInFacebookTwitterEmail this Story
  • Sandoz voluntarily recalls 24 lots of injectable methotrexate
    Novartis' Sandoz unit is recalling 24 lots of methotrexate -- a drug used to treat severe psoriasis, neoplastic diseases and rheumatoid arthritis -- after discovering glass particulates in the product. The recall affects vials of 50 milligrams per 2 milliliters and 250 milligrams per 10 milliliters. Sandoz has not received reports of adverse effects concerning the drug. Reuters (10/27) LinkedInFacebookTwitterEmail this Story
  • Other News
  Perfecting Your Practice 
  • Total body itch can leave doctors scratching their heads
    Dermatologists often see elderly patients complaining of total body itch that has no clear cause. Total body itch can be caused by excessively dry skin, pests, allergies, drug reactions or underlying disease, such as hypothyroidism, anemia or lymphoma, said dermatologist Dr. Joseph Bikowski. If no cause can be identified via a thorough work-up, doctors can try to treat the itch with fexofenadine, a nonsedative antihistamine, or prednisone. Modern Medicine/Dermatology Times (11/1) LinkedInFacebookTwitterEmail this Story
  • Survey: Practices using EHRs report long-term financial gain
    A Medical Group Management Association survey showed that independent practices as well as those owned by hospitals and integrated delivery systems reported higher revenues after adopting electronic health records compared with practices that use paper records. The survey also found that independent practices saw decreases in IT costs after the first year of EHR implementation. (11/2) LinkedInFacebookTwitterEmail this Story
  • Other News
  ASDS News 
  • Member-Get-A-Member Campaign
    The American Society for Dermatologic Surgery is excited to announce its Member-Get-A-Member Campaign, Aug. 15 to Dec. 31. This program gives you an exciting and rewarding opportunity to reach out to your colleagues and invite them to join the ASDS. Learn more here. LinkedInFacebookTwitterEmail this Story
  • State of the Art Cosmetic and Reconstructive Anatomy Course and Cadaver Lab in Miami
    The ASDS invites you to attend the State of the Art Cosmetic and Reconstructive Anatomy Course and Cadaver Lab in Miami on Dec. 4 and 5. This educational symposium is designed to provide a comprehensive review of advanced techniques for combined treatments in cosmetic and reconstructive dermatologic surgery. Thought leaders in the fields of anatomy and dermatologic surgery will share their expertise on procedures and treatments for optimal primary and post-reconstructive cosmetic outcomes. This course provides essential knowledge for dermatologic surgeons who treat cancer patients and perform reconstructive and cosmetic surgery. This interactive, live CME activity combines lecture, discussion and a five-hour hands-on cadaver lab. Get more information here. LinkedInFacebookTwitterEmail this Story
Learn more about ASDS ->Find a dermatologic surgeon  |  Why choose a dermatologic surgeon?  |  Join ASDS
2011 ASDS Annual Meeting

If you're not just a little bit nervous before a match, you probably don't have the expectations of yourself that you should have."
--Hale Irwin,
American professional golfer

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
A powerful website for SmartBrief readers including:
 Recent ASDS Skin Source SmartBrief Issues:   Lead Editor:  Adam Gaub
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005
© 1999-2011 SmartBrief, Inc.® Legal Information